Provided by Tiger Trade Technology Pte. Ltd.

Vanda Pharmaceuticals

5.28
-0.1000-1.86%
Pre-market: 5.390.1100+2.08%07:01 EDT
Volume:656.79K
Turnover:3.50M
Market Cap:319.24M
PE:-1.14
High:5.42
Open:5.42
Low:5.27
Close:5.38
52wk High:9.94
52wk Low:4.27
Shares:60.46M
Float Shares:47.66M
Volume Ratio:0.72
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6291
EPS(LYR):-3.7413
ROE:-77.81%
ROA:-22.38%
PB:1.45
PE(LYR):-1.41

Loading ...

Mar 13, 2020

Major Issues Report

Current report, item 8.01
Mar 03, 2020

Major Issues Report

Current report, item 5.02
Feb 26, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 26, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 20, 2020

Major Issues Report

Current report, item 5.02
Feb 19, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Jan 21, 2020

Major Issues Report

Current report, item 5.02
Jan 13, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 28, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities